Skip to Content
About Us Become an Authorised Buyer Medical Partners Blog Contact Us
🌐Ship toSelect country
  1. All products
  2. Shop by Area
  3. Nasolabial folds
  4. Teosyal RHA 2 Lidocaine - 2 x 1,0ml
  5. Nasolabial folds
Pricelist: Default Pricelist
Pricelist: Default Pricelist
Teosyal RHA 2 Lidocaine - 2 x 1,0ml

Teosyal RHA 2 Lidocaine - 2 x 1,0ml

Teosyal RHA 2 is a Teoxane RHA-technology cross-linked hyaluronic acid filler with 0.3% lidocaine, designed to create volume that corrects wrinkles and cutaneous depressions in mobile facial areas (cheeks, nasolabial folds, forehead, crow's feet) while preserving natural facial expression. For use by licensed, trained medical professionals only.

Cross-Linked Hyaluronic Acid FDA-Approved Lidocaine
148.00 € 148.00 €
  • Brand
Contact Us
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Teosyal®
SKU A5513 Share
Treatment Areas Crow's FeetForeheadLipsMarionette LinesNasolabial foldsNeckPerioral folds
Tags Cross-Linked Hyaluronic AcidFDA-ApprovedLidocaine

Teosyal RHA 2 is a mid-range formulation in Teoxane's RHA range, formulated at 23mg/ml, designed for correction of moderate dynamic wrinkles in mobile facial areas. Formulated with lidocaine for injection comfort.

CONCENTRATION

  • RHA-technology hyaluronic acid 23mg/ml
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 2 x 1.0ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Protect from direct sunlight

RESULTS & DURATION

Results typically last 12-15 months, depending on individual metabolism.

INDICATIONS

  • Moderate dynamic wrinkles
  • Nasolabial folds

TREATMENT AREAS

  • Nasolabial folds
  • Face, general

Teosyal RHA 2 is injected into the mid to deep dermis using linear threading or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin